MEG3 also can inhibit cholangiocarcinoma proliferation and invasion by inhibiting the major components of the PRC1 complex, B lymphoma Mo-MLV insertion region 1 (Bmi1), and RING finger protein 2 (RNF2) [80]. Here, RNF2 is linked to cholangiocarcinoma.